Biography

Ahmed Kamel Abdel Aal, MD, PhD, FSIR, is a Professor of Radiology and Internal Medicine, the Chief of Vascular and Interventional Radiology at The University of Texas Health Science Center at Houston (UTHealth), and the Director of Interventional Radiology at LBJ Hospital in Houston. Dr. Kamel is American Board-certified in Radiology and Interventional Radiology. He received fellowship training in Vascular and Interventional Radiology as well as Neuroradiology at the University of Alabama at Birmingham. Dr. Kamel holds a Master of Science and a PhD degree in Radiology. He was awarded the “Top ten faculty award for excellence in resident education” from the University of Alabama at Birmingham, the “Certificate of Merit Award” from the Radiological Society of North America, the “Certificate of Merit Award” from the American Roentgen Ray Society, the “Certificate of Outstanding performance in Veterans Affairs Radiology Service” and the “Louisville Slugger Award for best Board reviewer.” Dr. Kamel is also a fellow member of the Society of Interventional Radiology. His areas of clinical interest are Dialysis Interventions, Interventional Oncology, and Portal Hypertension Management.

CERTIFICATION:

  • Egyptian Board of Radiology, Cairo University, Egypt, 2000
  • American Board of Radiology, 2009
  • American Board of Interventional Radiology, Certificate and Added Qualification (CAQ), 2011

LICENSURE: 

  • Texas Medical License: FTL 46905, 2019-Present
  • Alabama Medical License: MD 37630, 2007 – 2019
  • Texas DEA Registration Number:  FA8839132, 2019 – Present

PROFESSIONAL ORGANIZATION MEMBERSHIP:

Regional:

  • Medical Association of the State of Alabama
  • Jefferson County Medical Society
  • Alabama Academy of Radiology (AAR)
  • Texas Radiological Society

 National:

  • Society of Interventional Radiology (SIR) – Fellow membership
    • Resident and Fellow Committee, 2014-present
    • Performance and Quality Improvement Committee, 2014-present
    • Diversity and Inclusion Committee, 2015-present
    • Quality and Outcome Division Committee, 2016-present
    • Standards of Practice Committee, 2016-present
    • International Education Exchange Committee, 2018-present
    • Abstract reviewer for the annual scientific meeting, 2018-present
    • Quality and Data Analysis Committee, 2019-present
    • International Annual Scientific Meeting Committee, 2021-present
  • Association of Chiefs of Interventional Radiology (ACIR)
    • Finance and Economics Committee, 2018-present
    • Operations Committee, 2018-present
  • Society of Interventional Oncology (SIO)
    • Co-founder of the Society
    • Membership Committee, August 2018-present
  • Radiological Society of North America (RSNA)
  • American Roentgen Ray Society (ARRS)
  • National Comprehensive Center Network (NCCN)
    •   NCCN “Conon/Rectal/Anal Cancers panel, 2012-2019
    •   Investigator for the NCCN oncology research program, 2012-present
  • Cancer Trials Support Unit (CTSU)
  • Eastern Cooperative Oncology Group (ECOG)

 International:

  • Society of African Interventional Radiology and Endovascular Therapy
  • (SAFIRE)
    • Co-founder of the Society
    • Chair of the bylaws committee, 2016-present
  • Middle East Endovascular Therapy Symposium (MEET Symposium)  
    • Co-founder of the Symposium
    • Scientific committee member, August 2016-present
  • International Society for Peritoneal Dialysis
    • Guidelines Working Group, 2018-present
  • Pan Arab Interventional Radiology Society
    • Scientific committee member, September 2020-present

Education

Bachelor of Medicine and Surgery
University of Cairo Medical School, Cairo, Egypt,1995
Masters of Science
University of Cairo Medical School, Cairo, Egypt, 2000
Philosophy of Doctorate, Diagnostic Radiology
University of Cairo Medical School, Cairo, Egypt, 2010
Internship
University of Cairo Medical School, Cairo, Egypt, 1996-1997
Diagnostic Radiology
University of Cairo Medical School, Cairo, Egypt, 1997-2000
Residency in Diagnostic Radiology
University of Alabama at Birmingham (UAB) Birmingham, Alabama, 2007
Fellowship in Vascular & Interventional Radiology
University of Alabama at Birmingham (UAB) Birmingham, Alabama, 2005
Fellowship in Neuroradiology
University of Alabama at Birmingham (UAB) Birmingham, Alabama, 2006

Areas of Interest

Clinical Interests

CURRENT TEACHING RESPONSIBILITIES

Participate in several teaching opportunities on both informal and formal levels within UAB and through outside teaching hospitals for medical students, residents, fellows and peers.

MENTORING ACTIVITIES

  1. Supervised several medical students from Egypt, Taiwan, China, Switzerland, Jordan,
    Bahrain, Brazil, Poland and India during their elective rotations in Interventional Radiology.
  2. Mentored NIH grant submission for Faculty in Nephrology.
  3. Mentored an international grant for a research fellow in Interventional Radiology.

CURRENT CLINICAL SERVICE RESPONSIBILITIES

  1. Chief of Vascular and Interventional Radiology
  2. Director of Interventional Radiology at Memorial Hermann Hospital.
  3. Director of Interventional Radiology at Lindon B. Johnson Hospital.

Research Interests

CURRENT GRANT SUPPORT:  
Industry sponsored trials:

  1. A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with either Durvalumab Monotherapy or Durvalumab plus Bevacizumab Therapy in Patients with Locoregional Hepatocellular Carcinoma (EMERALD-1), Astrazeneca. PI: Julie Rowe; 2020.
  2. A prospective, multicenter, open-label single arm study evaluating the safety and efficacy of selective internal radiation therapy (SIRT) using SIR-Spheres® Y-90 resin microspheres on duration of response (DoR) and objective response rate (ORR) in unresectable
    hepatocellular carcinoma (HCC) patients (DOORwaY90 Study), Sirtex Medical. PI: Ahmed Abdel Aal; 2022.
  3. A Prospective, Multi-Center Clinical Study of the BD® WavelinQTM EndoAVF System for the Creation of Arteriovenous (AV) Fistula in Patients Requiring Dialysis (CONNECT-AV), Bard Peripheral Vascular Inc. PI: Ahmed Abdel Aal; 2022.
  4. A Prospective, Global, Multicenter, Single Arm Post-Approval Study Investigating the Clinical Use and Safety of the Lutonix® Drug Coated Balloon PTA Catheter for the Treatment of Dysfunctional AV Fistulae (Lutonix AV PAS), Bard Peripheral Vascular Inc. PI: Ahmed Abdel Aal; 2022.
  5. A Retrospective, Multi-Center, Real-World Study Assessing the Clinical Use of BARD(tm) Long-Term Implantable Ports (Power and Non-Power), Bard Peripheral Vascular Inc. PI: Ahmed Abdel Aal; 2022.
  6. A Prospective, Multicenter, Pivotal Study with Randomized Controlled Prophylactic and Independent Therapeutic Cohorts to Evaluate the Safety and Efficacy of an Absorbable Inferior Vena Cava Filter for Pulmonary Embolism Prevention. PI: Ahmed Abdel Aal; 2023.

Investigator initiated trials:

  1. Embolization in Splenic Trauma (ELSA). Multicenter Study. Sponsor: Penumbra Inc. PI: Ahmed Abdel Aal; 2019.
  2. Identify Effective Biomarkers for Hepatocellular Carcinoma: A Pilot Study. PI: Ahmed Abdel Aal; 2019.
  3. Liver directed therapy for liver neoplasia: A single center experience. PI: Ahmed Abdel Aal; 2019.
  4. Database for liver directed therapy for liver neoplasia. PI: Ahmed Abdel Aal; 2019.
  5. Transjugular intrahepatic Porto-systemic shunt (TIPS): Single center experience. PI: Ahmed Abdel Aal; 2019.
  6. Renal ablative therapies for renal neoplasia: A single center experience. PI: Ahmed Abdel Aal; 2019.
  7. A humanitarian device exemption use protocol of Therasphere for treatment of unresectable hepatocellular carcinoma in patients with portal vein invasion. PI: Ahmed Abdel Aal; 2020.
  8. Identify effective biomarkers for hepatocellular carcinoma: Identify Proteomic biomarkers for outcome prediction of lipiodol TACE treatment. PI: Ahmed Abdel Aal; 2020.
  9. Combining blood and imaging biomarkers for precision treatment of hepatocellular carcinoma. PI: Ahmed Abdel Aal; 2020.
  10. Evaluation of Level 1 Trauma outcomes following implementation of new Interventional Radiology response protocol. PI: Ahmed Abdel Aal; 2021.
  11. Predictors for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Clinical Failure for the Treatment of Ascites and Hepatic Hydrothorax. PI: Ahmed Abdel Aal; 2021.
  12. Safety and Efficacy of IVUS Guided Biopsies. PI: Ahmed Abdel Aal; 2021.
  13. Ultrasound Guided Bone Marrow Biopsy is Reliable, Safe, and Cost-Effective. PI: Ahmed Abdel Aal; 2021.

PAST GRANT SUPPORT:
Industry sponsored trials:

  1. Phase 3 prospective, randomized, blinded and controlled investigation of hepasphere/quadrasphere microspheres for delivery of doxorubicin for the treatment of hepatocellular cancer (HiQuality), Merit Medical. PI: Ahmed Abdel Aal; 2011.
  2. Prospective, Multi-Center, Randomized, Concurrently-Controlled Study of the FLUENCY® PLUS Endovascular Stent Graft in the Treatment of In-stent Restenosis in the AV Access Venous Outflow Circuit (RESCUE), Bard Peripheral Vascular, Inc. PI: Ahmed Abdel Aal; 2011.
  3. Prospective, Multi-Center Study of the Bard® DenaliTM Retrievable Inferior Vena Cava Filter System, Bard Peripheral Vascular, Inc. PI: Ahmed Abdel Aal; 2011.
  4. S187.3.005 Open-Label Continuation Treatment Study With Levodopa – Carbidopa Intestinal Gel in Subjects with Advanced Parkinson’s Disease and Severe Motor-
    Fluctuations Who Have Exhibited A Persistent And Positive Effect To Treatment In Previous Studies. PI: David Standaert; 2011.
  5. ECOG 1208: A Phase III Randomized, Double-Blind Trial of Chemoembolization with or without Sorafenib in Unresectable Hepatocellular Carcinoma (HCC) in Patients with and without Vascular Invasion. PI: Carla Falkson; 2012.
  6. A Prospective, Multi-Center Study of the Novate Sentry Bioconvertible Inferior Vena Cava Filter (SENTRY), Novate. PI: Souheil Saddekni; 2015.
  7. A Prospective, Global, Multicenter, Randomized, Controlled Study Comparing Lutonix® 035 AV Drug Coated Balloon PTA Catheter vs. Standard Balloon PTA Catheter for the Treatment of Dysfunctional AV Fistulae. PI: Ahmed Abdel Aal; 2015.
  8. A Randomized Controlled Trial of Transcatheter Arterial Chemoembolization with Drug-Eluting Beads (DEB-TACE) Versus Sorafenib in the Treatment of Unresectable, Locally-Advanced Hepatocellular Carcinoma (SOLACE), PI: Ahmed Abdel Aal; 2016.
  9. EPOCH –A Phase III Clinical Trial Evaluating Therasphere® in Patients with Metastatic Colorectal Carcinoma of the Liver who have Failed First Line Chemotherapy. PI: Ahmed Abdel Aal; 2016.
  10. The Radiation-Emitting SIR-Spheres in Non-resectable (RESiN) Liver Tumor Patient Registry, Sirtex Medical. PI: Ahmed Abdel Aal; 2016.
  11. Surefire vs. Endhole for DEB-TACE: Quantifying Hepatic Artery Embolization to Improve Outcomes (Comparison of Two Different Catheter Systems for DEB-TACE), Surefire Medical. PI: Ahmed Abdel Aal; 2017.
  12. A clinical study to survey the experience and acceptability by physicians using BTG-13-002 (LC Bead LumiTM) for embolization procedures. PI: Souheil Saddekni; 2017.
  13. A Traditional Feasibility study of Gemcitabine, Cisplatin, and 90Y TARE for Unresectable Intrahepatic Cholangiocarcinoma (CTO 102254), Medical college of South Carolina. PI: Souheil Saddekni; 2017.
  14. Randomized study of IN.PACTTM AV access paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon vs. standard PTA for the treatment of obstructive lesions in the native arteriovenous dialysis fistulae (AVF). PI: Ahmed Abdel Aal; 2017.
  15. Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation [18F] Fluoromisonidazole (FMISO) Imaging. PI: Janis O’Malley; 2017.
  16. A Prospective, Global, Multicenter, Single Arm Post-Approval Study Investing the Clinical Use and Safety of the Lutonix Drug Coated Balloon PTA Catheter for Treatment of Dysfunctional AV Fistulae (LUTONIX AV PAS). PI: Ahmed Abdel Aal; 2018.
  17. Phase 1 Open Label, Multicenter Study of MK-1454 Administered by Intratumoral Injection as Monotherapy and in Combination with Pembrolizumab for Patients with Advanced/Metastatic Solid Tumors or Lymphomas. Sponsor: Merck medical. PI: Mansour Saleh; 2019.
  18. NCI Experimental Therapeutics-Clinical Trials Network with Phase 1 Emphasis. Sponsor: Mayo Clinic. PI: Mansour Saleh; 2019.
  19. A Prospective, Multi-Center, Single-Arm, Real World Study Assessing the Clinical Use of the CATERPILLARTM Arterial Embolization Device for Arterial Embolization in the Peripheral Vasculature (MONARCH), Bard Peripheral Vascular Inc. PI: Ahmed Abdel Aal; 2019.
  20. FLEX-AV Registry, VentureMed Group, Inc. PI: Ahmed Abdel Aal; 2019.
  21. A Prospective, Multi-Center, Single-Arm, Real World Study Assessing the Clinical Use of the CATERPILLARTM Arterial Embolization Device for Arterial Embolization in the Peripheral Vasculature (MONARCH). PI: Ahmed Abdel Aal; 2020.
  22. A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with either Durvalumab Monotherapy or Durvalumab plus Bevacizumab Therapy in Patients with Locoregional Hepatocellular Carcinoma. PI: Julie Rowe; 2020.
  23. A prospective, multicenter, open-label single arm study evaluating the safety and efficacy of selective internal radiation therapy (SIRT) using SIR-Spheres® Y-90 resin microspheres on duration of response (DoR) and objective response rate (ORR) in unresectable hepatocellular carcinoma (HCC) patients (DOORwaY90 Study), Sirtex Medical, PI: Ahmed Abdel Aal; 2021.
  24. A Prospective, Multi-Center Clinical Study of the BD® WavelinQTM EndoAVF System for the Creation of Arteriovenous (AV) Fistula in Patients Requiring Dialysis (CONNECT-AV), Bard Peripheral Vascular Inc. PI: Ahmed Abdel Aal; 2021.
  25. A Prospective, Global, Multicenter, Single Arm Post-Approval Study Investigating the Clinical Use and Safety of the LutonixTM Drug Coated Balloon PTA Catheter for the Treatment of Dysfunctional AV Fistulae (Lutonix AV PAS). Bard Peripheral Vascular Inc. PI: Ahmed Abdel Aal; 2022.

 Investigator initiated trials:

  1. Safety and efficacy of new drug eluting beads (Oncozene®) in transarterial chemoembolization of unresectable hepatocellular carcinoma. Preliminary results, CeloNova Biosciences, Inc. PI: Ahmed Abdel Aal; 2015.
  2. Use of Magnetic Resonance Imaging (MRI) angiography and Optical Coherence Tomography (OCT) to predict progressive Intimal hyperplasia and early graft thrombosis in arteriovenous graft (AVG) thrombosis. PI: Michael Alon; 2015.
  3. Outcomes of a new very small diameter drug eluting embolic beads for transarterial chemoembolization in unresectable hepatocellular carcinoma: a retrospective single center experience, Boston Scientific. PI: Ahmed Abdel Aal; 2016.
  4. Embolization in Splenic Trauma (ELSA). Pilot Study. Sponsor: UAB Department of Radiology. PI: Andrew Gunn; 2022.
  5. A Prospective, Global, Multicenter, Single Arm Post-Approval Study Investing the Clinical Use and Safety of the Lutonix Drug Coated Balloon PTA Catheter for Treatment of Dysfunctional AV Fistulae (LUTONIX AV PAS). PI: Ahmed Abdel Aal; 2022.
  6. Embolization in Splenic Trauma (ELSA). Multicenter Study. Sponsor: Penumbra Inc. PI: Andrew Gunn; 2019.

 Unrestricted grants:

  1. Unrestricted grant, BTG International Inc.; 2014.
  2. Unrestricted grant, Covidien Ltd.; 2014.
  3. Unrestricted grant, Bard Peripheral Vascular; 2015.
  4. Unrestricted grant, Boston Scientific; 2016
  5. Unrestricted grant, Sirtex; 2016.
  6. Unrestricted grant, Sirtex; 2021.

 RESEARCH IN PROGRESS: 

  1. Internal Iliac Artery Embolization During Endovascular Aortoiliac Aneurysm Repair: Use of Three- Dimensional Volume-Rendered Reconstruction and Amplatzer Vascular Plug II Reduces Radiation Exposure to the Patient. PI: Ahmed M. K. Abdel Aal, 2010.
  2. Outcomes of a new very small diameter drug eluting embolic beads for transarterial chemoembolization in unresectable hepatocellular carcinoma in BCLC-C patients: a retrospective single center experience, Boston Scientific. PI: Ahmed Abdel Aal; 2019.
  3. Liver directed therapy: A single center experience. PI: Ahmed Abdel Aal; 2020.
  4. Liver directed therapy for liver neoplasia: A single center experience. PI: Ahmed Abdel Aal; 2018.
  5. Embolization in Splenic Trauma (ELSA). Multicenter Study. Sponsor: Penumbra Inc. PI: Andrew Gunn; 2019.
  6. Database for renal ablative therapies for renal tumors. PI: Ahmed Abdel Aal; 2020.
  7. Renal ablative therapies for renal neoplasia: A single center experience. PI: Ahmed Abdel Aal; 2020.
  8. Transjugular intrahepatic porto-systemic shunt (TIPS). A single center experience. PI: Ahmed Abdel Aal; 2020.
  9. A humanitarian device exemption use protocol of Therasphere for treatment of unresectable hepatocellular carcinoma in patients with portal vein invasion. PI: Ahmed Abdel Aal; 2020.
  10. Identify effective biomarkers for hepatocellular carcinoma: Identify Proteomic biomarkers for outcome prediction of lipiodol TACE treatment. PI: Ahmed Abdel Aal; 2020.
  11. Combining blood and imaging biomarkers for precision treatment of hepatocellular carcinoma. PI: Ahmed Abdel Aal; 2020.
  12. A Prospective, Multi-Center, Single-Arm, Real World Study Assessing the Clinical Use of the CATERPILLAR™ Arterial Embolization Device for Arterial Embolization in the Peripheral Vasculature (MONARCH). PI: Ahmed Abdel Aal; 2020.
  13. A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with either Durvalumab Monotherapy or Durvalumab plus Bevacizumab Therapy in Patients with Locoregional Hepatocellular Carcinoma. PI: Julie Rowe; 2020.
  14. A prospective, multicenter, open-label single arm study evaluating the safety and efficacy of selective internal radiation therapy (SIRT) using SIR-Spheres® Y-90 resin microspheres on duration of response (DoR) and objective response rate (ORR) in unresectable hepatocellular carcinoma (HCC) patients (DOORwaY90 Study), Sirtex Medical, PI: Ahmed Abdel Aal; 2021.
  15. A Prospective, Multi-Center Clinical Study of the BD® WavelinQ™ EndoAVF System for the Creation of Arteriovenous (AV) Fistula in Patients Requiring Dialysis (CONNECT-AV), Bard Peripheral Vascular Inc. PI: Ahmed Abdel Aal; 2021.
  16. A Prospective, Global, Multicenter, Single Arm Post-Approval Study Investigating the Clinical Use and Safety of the LutonixTM Drug Coated Balloon PTA Catheter for the Treatment of Dysfunctional AV Fistulae (Lutonix AV PAS). Bard Peripheral Vascular Inc. PI: Ahmed Abdel Aal; 2022.
  17. Assessment of Simultaneous Portal and Systemic Coagulation by Visco-Elastic Analysis. Sub-I: Ahmed Abdel Aal; 2022.

Publications

**Faculty profiles will only highlight current information (the last three years). Please see the faculty’s CV for more information.

ABSTRACTS

  1. Mahmoud K, El Khudari H, Souid A, Abdel Aal AK. Safety and efficacy of 75 microns drug eluting embolic used in chemoembolization of advanced stage hepatocellular carcinoma. Pan Arab Interventional Radiology Society (PAIRS) annual meeting, Dubai, UAE, May 2022.
  2. Krebs H, Gandhi R, Collins Z, O’Hara R, Akhter N, Wang E, Grilli C, Brower J, Peck S, Petroziello M, Abdel Aal AK, Golzarian J, Kennedy A, Matsuoka L, Sze D, Brown D. Impact of SIRFLOX/FOXFIRE trials on Utilization of Transarterial Radioembolization for Metastatic Colorectal Carcinoma. Global Embolization Oncology Symposium Technologies (GEST) annual meeting, New York, USA, May 2022.
  3. Emmons E, Krebs H, Gandhi R, Collins Z, O’Hara R, Akhter N, Wang E, Grilli C, Brower J, Peck S, Petroziello M, Abdel Aal AK, Golzarian J, Kennedy A, Matsuoka L, Sze D, Brown D. Survival outcomes and toxicities following Y90 radioembolization of colorectal cancer metastatic to the liver: 498 patient analysis from the RESiN Registry (NCT: 02685631). Society of Interventional Radiology (SIR) Annual Scientific Meeting, Boston, Massachusetts, USA, June 2022.
  4. Wang H, You L, Zhou X, Surabhi V, Matta E, Abdel Aal AK. Artificial Intelligence-mediated Multidisciplinary Approaches for Hepatocellular Carcinoma Early Diagnosis. Society of Interventional Radiology (SIR) Annual Scientific Meeting, Boston, Massachusetts, USA, June 2022.
  5. White S, Abdel Aal AK, Ghandi RT, Kalva S, Golzarian J, Collins Z, Haste P, Foteh M, Lunch F, Cornejo S, Rilling W. Interim results of a prospective, multicenter, single-arm, real world study assessing the clinical use of the caterpillar embolization device for arterial embolization in peripheral vasculature (MONARCH). Society of Interventional Radiology (SIR) Annual Scientific Meeting, Boston, Massachusetts, USA, June 2022.
  6. Rohr A, Collins Z, Hodson A, Zhang K, Krebs H, Gandhi R, O’Hara R, Akhter N, Wang E, Grilli C, Brower J, Peck S, Petroziello M, Abdel Aal AK, Golzarian J, Brown D. Multi-institutional review of patients receiving yttrium(Y)-90 transarterial radioembolization (TARE) with hepatic tumors status post partial hepatectomy. Society of Interventional Radiology (SIR) Annual Scientific Meeting, Boston, Massachusetts, USA, June 2022.
  7. Claus L, Foss W, Connors T, Yue J, Zhang X, Tapnio R, Bassuner J, Abdel Aal AK, Patel M. TIPS for Refractory Ascites: Portosystemic Gradient Reduction Parameters. Texas Radiologic Society (TRS), Austin, Texas, USA, February 2023.
  8. Bishay S, Emmons E, Du L, Krebs H, Gandhi RT, Collins ZS, O’Hara R, Akhter NM, Wang EA, Grilli CJ, Brower JS, Peck SR, Petroziello M, Abdel Aal AK, Golzarian J, Kennedy AS, Matsuoka L, Sze DY, Brown DB. Comparing Survival Outcomes and Toxicities of Y90 Radioembolization of Colorectal Cancer Metastatic to the Liver Between Patients Older and Younger than 70: Analysis from the RESIN Registry (NCT02685631). Society of Interventional Radiology (SIR) Annual Scientific Meeting, Phoenix, Arizona, USA, March 2023.
  9. Bassuner J, Patel M, Ahuja RS, Shahin MS, Abdel Aal AK. New Kids on the Block: Current Venous Thrombectomy Devices. Society of Interventional Radiology (SIR) Annual Scientific Meeting, Phoenix, Arizona, USA, March 2023.

REFEREED ARTICLES

  1. Elkhudari H, Abdel Aal AK, Abaza M, Almehmi SE, Sachdeva B, Almehmi A. Peritoneal dialysis catheter placement: Percutaneous and peritoneoscopic techniques. Semin intervent Radiol 2022; 39 (01): 023-031.
  2. Oza-Gajera BP, Abdel Aal AK, Almehmi A. Complications of percutaneous peritoneal dialysis catheter. Semin intervent Radiol 2022; 39 (01): 40-46.
  3. Bassuner J, Kowalcyzt B, Abdel Aal AK. Why peritoneal dialysis is underutilized in the United States: A review of inequities. Semin intervent Radiol 2022; 39 (01): 47-50
  4. Abdel Aal AK, Jefferson X, Klusman C, Garcia L, Hassanein H, Abdel Aal T, Shahin M. Devices and techniques for percutaneous creation of dialysis arteriovenous fistulas. Semin intervent Radiol 2022; 39 (01): 66-74.
  5. Habash M, Murray A, Heeke BL, Li Y, Mahmoud KH, Saddekni S, Abdel Aal AK, Gunn AJ. Outcomes of transjugular intrahepatic portosystemic shunt using 12mm diameter polytetrafluoroethylene-covered stents in cirrhotic patients with portal hypertension. Diagn Interv Radiol 2022; 28: 239-243.
  6. Fiala M, Azaria A, Woo J, Abdel Aal AK, Levey A. Treating Phantom Limb Pain: Cryoablation of the Posterior Tibial Nerve. Radiol Case Rep 2022; 3168-3171.
  7. Emmons E, Bishay S, DU L, Krebs H, Gandhi RT, Collins ZS, O’Hara R, Akhter NM, Wang EA, Grilli C, Brower JS, Peck SR, Petroziello M, Abdel Aal AK, Golzarian J, Kennedy AS, Matsuoka L, Sze DY, Brown DB. Survival and toxicities after Y90 transarterial radioembolization of metastatic colorectal cancer in the RESiN registry. Radiology 2022; 1-9.
  8. Girgis S, Niknam N, Bhatti Z, Mohsin J, Abdel Aal AK, Hariharan R, Hematpour K. A Case of Combined Pulmonary Vein Isolation (PVI) & Watchman Implant Through Hepatic Vein in a Patient with Interrupted Inferior Vena Cava (IVC). Clinical Case
    Reports 2023; 11: 8. DOI: 10.22541/au.168363934.47998534/v1. https://doi.org/10.1002/ccr3.7787

CHAPTERS

  1. Abdel Aal AK, Klusman C, Garcia L, Jefferson X, Irshad OM, Abdel Aal T, Hoang B, Burris J, Celii FG, Ljuboja D. Vascular Anatomy of the Head and Neck. Academy of Online Radiology Education (Acore), 2022.
  2. Abdel Aal AK, Klusman C, Garcia L, Jefferson X, Irshad OM, Abdel Aal T, Hoang B, Burris J, Celii FG, Ljuboja D. Vascular Anatomy of the Thorax. Academy of Online Radiology Education (Acore), 2022.
  3. Abdel Aal AK, Klusman C, Garcia L, Jefferson X, Irshad OM, Abdel Aal T, Hoang B, Burris J, Celii FG, Ljuboja D. Vascular Anatomy of the Abdomen. Academy of Online Radiology Education (Acore), 2022.
  4. Abdel Aal AK, Klusman C, Garcia L, Jefferson X, Irshad OM, Abdel Aal T, Hoang B, Burris J, Celii FG, Ljuboja D. Vascular Anatomy of the upper and lower extremities. Academy of Online Radiology Education (Acore), 2022.
  5. Abdel Aal AK, Klusman C, Garcia L, Jefferson X, Irshad OM, Abdel Aal T, Hoang B, Burris J, Celii FG, Ljuboja D. Paracentesis. Academy of Online Radiology Education (Acore), 2022.
  6. Abdel Aal AK, Klusman C, Garcia L, Jefferson X, Irshad OM, Abdel Aal T, Hoang B, Burris J, Celii FG, Ljuboja D. Peripherally inserted central venous catheter placement. Academy of Online Radiology Education (Acore), 2022.
  7. Abdel Aal AK, Klusman C, Garcia L, Jefferson X, Irshad OM, Abdel Aal T, Hoang B, Burris J, Celii FG, Ljuboja D. Thoracentesis. Academy of Online Radiology Education (Acore), 2022.
  8. Abdel Aal AK, Klusman C, Garcia L, Jefferson X, Irshad OM, Abdel Aal T, Hoang B, Burris J, Celii FG, Ljuboja D. Superficial tissue biopsies. Academy of Online Radiology Education (Acore), 2022.

SCIENTIFIC EXHIBITS

  1. Abdel Aal AK, Mahmoud K, Fadala H, Souid A, Ahmed M, Abou Elkassem A, Osman S, Shoreibah M, El Khudari H. Safety and efficacy of transarterial chemoembolization using small diameter drug eluting beads followed by microwave ablation for the treatment of unresectable hepatocellular carcinoma. European Congress of Radiology (ECR), Vienna, Austria, February 2020.
  2. Abdel Aal AK, Osman S, Fayez M, Fadala H, Souid A, Abou Elkassem A, Li Y, Shoreibah M, Mahmoud K. Safety and efficacy of transarterial chemoembolization using small diameter drug eluting beads followed by microwave ablation for the treatment of unresectable hepatocellular carcinoma. Society of Interventional Radiology (SIR) Annual Scientific Meeting, Seattle, Washington, USA, March 2020.
  3. Abdel Aal AK, Osman S, Fayez M, Souid A, Mahmoud K, Abou Elkassem A, Shoreibah M. Comparison between ultrasound and angiographic findings in patients presenting with recurrent ascites and undergoing transjugular intrahepatic portosystemic shunt revision. Society of Interventional Radiology (SIR) Annual Scientific Meeting, Seattle, Washington, USA, March 2020.
  4. Gayed I, Cohen A, Kaur H, Abdel Aal AK. Selective high dose Y-90 Theraspheres treatment of malignant liver lesions. Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, New Orleans, Louisiana, USA, June 2020.

VIDEO AND WEB PRESENTATIONS

  1. Web presentation on: Percutaneous dialysis arteriovenous fistula creation. Saudi Interventional Radiology Society (SIRS), May 2020.
  2. Web presentation on: Peritoneal dialysis catheter placement using ultrasound and fluoroscopy guidance. Baxter, May 2020.
  3. Web presentation on: Peritoneal dialysis catheter placement using ultrasound and fluoroscopy guidance. Baxter, June 2020.
  4. Web presentation on: Endo-AVF: An attractive option for dialysis fistula creation”. Bard, June 2020.
  5. Web presentation on: Peritoneal dialysis catheter placement using ultrasound and fluoroscopy guidance. Baxter, July 2021.

INVITED LECTURES AND WORKSHOPS (NATIONAL AND INTERNATIONAL)

  1. “How to create dialysis fistula by Interventional Radiology”. Moroccan School of Interventional Radiology Diploma, sponsored by the Moroccan Society of Interventional Radiology. February 2022.
  2. “Endo AVF: outcomes and follow up”. EndoVascular and Interventional Symposium (EVIS), sponsored by the Turkish Society of Interventional Radiology annual meeting, March 2022.
  3. “Endovascular management of non-variceal upper gastrointestinal bleeding”. Radiology Grand rounds, Emory University in collaboration with Road to IR (Road2IR) and Health for the world (H4TW), Rad-Aid, Atlanta, USA, May 2022.
  4. “Radiation Segmentectomy: Curative intent, Bridging/downstaging”. Pan Arab Interventional Radiology Society (PAIRS) annual conference, Dubai, United Arab Emirates, May 2022.
  5. “Flow modifying microcatheters: are they ready for prime time?”. Pan Arab Interventional Radiology Society (PAIRS) annual conference, Dubai, United Arab Emirates, May 2022.
  6. “EndoAVF: Devices, techniques and secondary interventions”. Pan Arab Interventional Radiology Society (PAIRS) annual conference, Dubai, United Arab Emirates, May 2022.
  7. “Peritoneal dialysis catheter placement”. Peritoneal dialysis workshop. Pan Arab Interventional Radiology Society (PAIRS) annual conference, Dubai, United Arab Emirates, May 2022.
  8. “Endo AVF: outcomes and follow up”. EndoAVF workshop. Pan Arab Interventional Radiology Society (PAIRS) annual conference, Dubai, United Arab Emirates, May 2022.
  9. “Devices and techniques”. EndoAVF workshop. Pan Arab Interventional Radiology Society (PAIRS) annual conference, Dubai, United Arab Emirates, May 2022.
  10. “EndoAVF case presentation”. Pan Arab Interventional Radiology Society (PAIRS) annual conference, Dubai, United Arab Emirates, May 2022.
  11. “Overview of available flow modifying microcatheters”. Global Embolization Oncology Symposium Technologies (GEST) annual meeting, New York, USA, May 2022.
  12. “How SIR-Spheres and personalized dosimetry can improve patient outcomes”. Global Embolization Oncology Symposium Technologies (GEST) annual meeting, New York, USA, May 2022.
  13. “Transjugular Intrahepatic Portosystemic Shunt”. Diagnostic and Interventional Radiology Congress, Tanger, Morocco, May 2022.
  14. “Endovascular management of non-variceal gastrointestinal bleeding”. Diagnostic and Interventional Radiology Congress, Tanger, Morocco, May 2022.
  15. “Angioclub workshop: Dosimetry”. Society of Interventional Radiology (SIR) Annual Scientific Meeting, Boston, Massachusetts, USA, June 2022.
  16. “EndoAVF: Tips and Tricks”. Endo Vascular Access (EVA) annual meeting, Patras, Greece, June 2022.
  17. “Digital Subtraction Angiography: Can it stand alone?”. Endo Vascular Access (EVA) annual meeting, Patras, Greece, June 2022.
  18. “Paclitaxel-Coated Balloons: Still Debatable”. Endo Vascular Access (EVA) annual meeting, Patras, Greece, June 2022.
  19. “Innovations in Interventional Oncology”, Keynote presentation. International Gastrointestinal, Liver and Uro-oncology Conference (IGILUC), Cairo, Egypt, July 2022.
  20. “Optimizing outcomes from DEB-TACE”. International Gastrointestinal, Liver and Uro-oncology Conference (IGILUC), Cairo, Egypt, July 2022.

INVITED LECTURES AND PROFESSORSHIPS (LOCAL AND REGIONAL)

  1. “Endovascular management of portal hypertension (part 1): TIPS and DIPS”. Hepatology and Gastroenterology grand rounds, University of Texas health science center at Houston, Houston, Texas, January 2021.

COURSE ORGANIZER

  1. Moderator, Dialysis interventions session, EndoVascular and Interventional Symposium (EVIS), sponsored by the Turkish Society of Interventional Radiology annual meeting, March 2022.
  2. Organizer, EndoAVF workshop. Pan Arab Interventional Radiology Society (PAIRS) annual conference, Dubai, United Arab Emirates, May 2022.
  3. Organizer Peritoneal dialysis workshop. Pan Arab Interventional Radiology Society (PAIRS) annual conference, Dubai, United Arab Emirates, May 2022.
  4. Moderator, SAFIRE meets PAIRS session. Pan Arab Interventional Radiology Society (PAIRS) annual conference, Dubai, United Arab Emirates, May 2022.
  5. Moderator, Dialysis summit. Pan Arab Interventional Radiology Society (PAIRS) annual conference, Dubai, United Arab Emirates, May 2022.
  6. Moderator, EndoAVF case presentations. Pan Arab Interventional Radiology Society (PAIRS) annual conference, Dubai, United Arab Emirates, May 2022.
  7. Moderator, WaveinQ EndoAVF System: Not just Creating an AV fistula, Making a Difference. Pan Arab Interventional Radiology Society (PAIRS) annual conference, Dubai, United Arab Emirates, May 2022.
  8. Moderator, Masterclass Particles, Resorbable and Microcatheters and Panel Discussion. Global Embolization Oncology Symposium Technologies (GEST) annual meeting, New York, USA, May 2022.
  9. Moderator and Panelist, How SIR-Spheres and personalized dosimetry can improve patient outcomes. Global Embolization Oncology Symposium Technologies (GEST) annual meeting, New York, USA, May 2022.
  10. Moderator, HCC Session. International Gastrointestinal, Liver and Uro-oncology Conference (IGILUC), Cairo, Egypt, July 2022.
  11. Moderator, Bone and pain interventions. International Gastrointestinal, Liver and Uro-oncology Conference (IGILUC), Cairo, Egypt, July 2022.
  12. Moderator, Keynote lecture. International Gastrointestinal, Liver and Uro-oncology Conference (IGILUC), Cairo, Egypt, July 2022.

COURSE PROCTOR

  1. Proctor of a course on “Percutaneous arteriovenous fistula creation”, Washington, DC, September 2019.
  2. Proctor, Radioembolization Summit. International Gastrointestinal, Liver and Uro-oncology Conference (IGILUC), Cairo, Egypt, July 2022.